HF
MYGN icon

HRT Financial’s Myriad Genetics MYGN Stock Holding History

HRT Financial’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Sell
542,464
-1,243,855
-70% -$5.65M 0.01% 1443
2026
Q1 		$8.04M Buy
1,786,319
+1,317,451
+281% +$6.86M 0.02% 722
2025
Q4 		$2.88M Sell
468,868
-321,701
-41% -$2.33M 0.01% 1070
2025
Q3 		$5.71M Buy
790,569
+650,669
+465% +$3.86M 0.02% 629
2025
Q2 		$742K Buy
+139,900
New +$826K ﹤0.01% 1414
2024
Q4 		– Sell
-22,193
Closed -$607K – 2949
2024
Q3 		$607K Buy
+22,193
New +$601K ﹤0.01% 1499
2023
Q4 		– Sell
-70,472
Closed -$1.13M – 2816
2023
Q3 		$1.13M Buy
+70,472
New +$1.34M 0.01% 900
2023
Q2 		– Sell
-103,309
Closed -$2.4M – 2976
2023
Q1 		$2.4M Buy
103,309
+65,916
+176% +$1.34M 0.03% 507
2022
Q4 		$542K Buy
+37,393
New +$697K 0.01% 1354
2022
Q2 		– Sell
-41,813
Closed -$1.05M – 3431
2022
Q1 		$1.05M Buy
+41,813
New +$1.07M 0.01% 984
2021
Q1 		– Sell
-28,227
Closed -$558K – 2992
2020
Q4 		$558K Sell
28,227
-10,797
-28% -$174K 0.01% 970
2020
Q3 		$508K Buy
+39,024
New +$494K 0.01% 868

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HRT Financial's MYGN Position: Q2 2026 in Review

HRT Financial reduced its Myriad Genetics (MYGN) stake by 70% in Q2 2026, selling an estimated $5.65M and leaving 542,464 shares worth $3.1M. The position accounts for 0.01% of the portfolio, ranked #1443.

HRT Financial first reported a position in MYGN in Q3 2020 and has held it in 12 quarters since. The position peaked at $8.04M in Q1 2026. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • HRT Financial held 542,464 shares of Myriad Genetics worth $3.1M as of Q2 2026.
  • HRT Financial sold 1,243,855 Myriad Genetics shares in Q2 2026, an estimated $5.65M.
  • Myriad Genetics made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1443 holding.
  • HRT Financial first reported a position in Myriad Genetics in Q3 2020 and has held it in 12 quarters since.
  • HRT Financial's Myriad Genetics position peaked at $8.04M in Q1 2026.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.